Skip to content

Study the effect of Gojivhadi Malahara (Ointment) for the Treatment of Napkin Dermatitis (Ahiputana)

A Single Arm Clinical Study to evaluate the efficacy of Gojivhadi Malahara in Ahiputana (Napkin Dermatitis) in infants.

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049832
Enrollment
38
Registered
2023-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Umang Varshney
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Infants who suffer with Ahiputana. 2)Infants age up to 1 year. 3)Patients will be selected irrespective of sex and socioeconomic status. 4)The Patients whose parents are ready to participate in the clinical trial by giving informed written consent.

Exclusion criteria

Exclusion criteria: 1)Infants having other generalized skin infections. 2)Infants having life threatening illness. 3)Infants who are known case of systemic illness. 4)Infants who have other than clinical signs and symptoms of Ahiputana. 5)Children above 1 year of age. 6)History of Ahiputana more than 10 days.

Design outcomes

Primary

MeasureTime frame
To decrease kandu(itching) and pidika over perianal region.Timepoint: 7 days study with follow up on 3rd and 7th day(0,3,7)

Secondary

MeasureTime frame
To Observe the adverse effects , if anyTimepoint: 7 days study with follow up on 3rd and 7th day(0,3,7)

Countries

India

Contacts

Public ContactDr Umang Varshney

Dr. D. Y. Patil college of Ayurved and Research Centre

sbhagwat777@gmail.com9511223623

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026